Sumitomo Pharma Co Ltd (OTCPK:DNPUF)
$ 8.4 (0%) Market Cap: 3.52 Bil Enterprise Value: 4.54 Bil PE Ratio: 4.78 PB Ratio: 1.74 GF Score: 65/100

Full Year 2026 Sumitomo Pharma Co Ltd Earnings Presentation Transcript

May 13, 2026 / NTS GMT
Release Date Price: $10.5

May 13, 2026 / NTS GMT
Presentation
May 13, 2026 / NTS GMT

=====================
Corporate Participants
=====================
* Toru Kimura
Sumitomo Pharma Co Ltd - President, Representative Director
* Megumi Maruyama
Sumitomo Pharma Co Ltd - Vice President, Head - Corporate Communications
* Tsutomu Nakagawa
Sumitomo Pharma Co Ltd - Managing Executive Officer, Director
* Motoyuki Sakai
Sumitomo Pharma Co Ltd - Executive Vice President, Representative Director
* Yumi Sato
Sumitomo Pharma Co Ltd - Managing Executive Officer, Chief Director of R&D

=====================
Conference Call Participants
=====================
* Stephen Barker
Jefferies LLC - Analyst
* Hidemaru Yamaguchi
Citi Infrastructure Investments LLC - Analyst
* Seiji Wakao
JPMorgan Chase & Co - Analyst
* Hiroshi Wada
SMBC Nikko Securities Inc - Analyst
* Jaeheon Lee
Morgan Stanley & Co Ltd - Analyst
* Kazuaki Hashiguchi
Daiwa Securities Group Inc - Analyst

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
7-Day Free Trial · Cancel Anytime
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot